Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study of Venetoclax in Combination With Azacitidine in Indian Subjects With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

NCT07044687 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07044687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07044687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study of Venetoclax in Combination With Azacitidine in Indian Subjects With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
Lead sponsor
AbbVie
Phase
Phase 4
Overall status
Recruiting
Start date
July 24, 2025
Completion date
November 30, 2027
Enrollment
100 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia